Pharmaceuticals
10 CMOs in Pharmaceuticals
These ten executives hold chief marketing officer titles at pharmaceutical companies, in global, regional and country roles. A reader can learn from them how pharmaceutical marketing organizations are structured and how marketing leaders plan launches and work across brands and markets.
Professionals to explore
01—10Andrea Kurz
LinkedInExperience: Chief Marketing Officer Oncology - EEMEA region, Executive Director · MSD
Chief Marketing Officer Oncology - EEMEA region, Executive Director at MSD since December 2023, after serving as Executive Business Unit Director Oncology (2019–2023). Earlier MSD roles include Regional Marketing Lead Oncology - EMEAC Region (Assignment) (2018–2019) and Pricing Manager (Market Access) (2014–2016).
Bhupati Roy
LinkedInExperience: Chief Marketing Officer · Healthcare Pharmaceuticals Limited
Chief Marketing Officer at Healthcare Pharmaceuticals Limited since February 2025. At the same company he has been Executive Director Marketing since 2016 and was Director, Marketing (2013–2016) and General Manager, Marketing (2004–2012); he was also Executive Director at RAK Pharmaceuticals Pvt. limited (2012–2013).
Gail Horwood
LinkedInExperience: Chief Marketing and Customer Experience Officer, Innovative Medicines, US · Novartis
Chief Marketing and Customer Experience Officer, Innovative Medicines, US at Novartis since November 2021, after serving as Chief Experience Officer and Head of Digital Customer Engagement, US Pharma (2021). The profile says she designed and governs a centralized U.S. marketing and customer experience model spanning 24 products and 36 indications. She was previously Chief Marketing Officer, North America at Kellogg Company (2019–2021).
Jasveen Chugh
LinkedInExperience: Executive Director, Pharmaceuticals Business Unit & Chief Marketing Officer, UK · MSD in the UK
Executive Director, Pharmaceuticals Business Unit & Chief Marketing Officer, UK at MSD in the UK since May 2024. Before MSD, Chugh held senior director roles at UCB, including Senior Director, Global Franchise Head HS (Hidradenitis Suppurativa), Immuno-dermatology (2019–2023) and Senior Director, Franchise Head, Immuno-dermatology, BII (2023–2024).
Jon Gergis
LinkedInExperience: Chief Marketing Officer · AiPharma
Chief Marketing Officer at AiPharma since August 2021. The profile describes designing and managing the global launch blueprint for Avigan and Qifenda and creating a commercialization roadmap covering product development, regulatory, marketing and sales launch plans. Earlier roles include Vice President, Sales and Marketing at Novartis (2000–2006) and Business Unit Manager at Merck (1998–2000).
Lina Polimeni
LinkedInExperience: Senior Vice President and Chief Marketing Officer - Consumer · Eli Lilly and Company
Senior Vice President and Chief Marketing Officer - Consumer at Eli Lilly and Company since October 2025, after serving at Lilly as Chief Media Officer- Lilly USA (2019–2023) and Chief Corporate Brand Officer (2023–2025). Her earlier Lilly roles include Senior Director- Consumer Marketing Diabetes Business Unit (2017–2018).
Mike Davis
LinkedInExperience: SVP, Chief Marketing Officer, Head of Stakeholder Integration · UCB
SVP, Chief Marketing Officer, Head of Stakeholder Integration at UCB since September 2024, alongside the Head of WW Epilepsy & Rare Organization role he has held since 2022. Earlier at UCB he was Head of U.S. Neurology & Rare (2017–2022) and VP, Head of Seizure Freedom Patient Value Mission (2015–2017). His profile describes more than two decades in the pharmaceutical and biotech sector across the U.S., Europe and Asia-Pacific.
Prentice Stovall
LinkedInExperience: Sr. Vice President, Immunology Strategy & Global Marketing - Chief Marketing Officer · Eli Lilly and Company
Sr. Vice President, Immunology Strategy & Global Marketing - Chief Marketing Officer at Eli Lilly and Company since November 2023. Earlier Lilly roles include Head of Global Brand Development, Immunology for an in-market molecule (2020) and a pre-launch molecule (2020–2023), and Vice President, International Therapeutic Area Leader (Portfolio) in 2023.
Sabine Akiki
LinkedInExperience: Chief Marketing Officer · Eli Lilly and Company
Chief Marketing Officer at Eli Lilly and Company since September 2024; the profile headline gives the role as Chief Marketing Officer - Japan, based in Kobe. At Lilly she also served as Business Unit Director - Oncology (2020–2025) and as Communication, Public & Governmental Affairs Director (2019–2020).
Vinayak Shenoy
LinkedInExperience: Chief Marketing Officer · Anuh Pharma Limited
Chief Marketing Officer at Anuh Pharma Limited since August 2025; the profile headline gives the role as Chief Marketing Officer-Mature Markets. Before that he was Business Head-Regulated markets at Exemed Pharmaceuticals (2021–2025) and Senior Manager International Marketing at ZCL Chemicals Ltd (2017–2021).
Choose the right perspective
Match the scope of the role to your question: a global or regional marketing chief can speak to portfolio and launch strategy across markets, while a country marketing chief knows local execution. Also weigh company size, since marketing at a large multinational runs differently from marketing at a smaller or regional drug maker.
Questions to take into the conversation
- 01How did you structure the marketing organization across brands, therapeutic areas and countries, and what would you change about that structure today?
- 02What does a strong launch plan look like in your experience, and which parts of it are most often underfunded or started too late?
- 03How do you divide responsibility between marketing, sales, market access and medical teams when a brand is under pressure?
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot and may describe past or present roles. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.
Request a correction or removal